Boots new owner 2026: what the Weston deal could mean for you

The new Boots owner for 2026 is set to be Wittington Investments, the holding company of Canada’s Weston family. It agreed this week to buy the pharmacy and beauty chain from Sycamore Partners, according to BNN Bloomberg, which said the announcement came on Wednesday. The deal has not yet completed, so nothing has changed at the tills or the pharmacy counter.

This guide sets out what has been agreed, what the owners have said they want to do, and what that could mean for shoppers, patients and staff. Where the sources are silent, we say so.

Boots ownership change: what has been agreed

BeBeez reported that Wittington has signed a definitive agreement and will keep operational control. Its Toronto-listed co-investor, Fairfax Financial Holdings, will hold 50% of the equity. The deal needs the usual approvals and, according to BeBeez, may complete in the first quarter of 2027. BeBeez reported that Galen Weston, Wittington’s chairman, will head Boots.

The price differs between reports. Some of the gap reflects the mix of currencies and whether debt is included, but the sources do not fully explain the differences. The figures below are as each outlet gave them.

For comparison, Sycamore’s 2025 takeover of Walgreens Boots Alliance valued the group at just under $10bn in equity, according to The National, or just under $24bn including debt. The Boots business is now being sold on its own. Wittington said it sees an opportunity through “stable, long-term ownership, new capital investment and a renewed operational focus”, according to BeBeez.

Boots takeover: pay, conditions and prices

On pay, the honest answer is that nothing has been announced. Boots has more than 1,800 shops and 50,000 workers in the UK and Ireland, according to BeBeez. None of the five sources we reviewed says anything about wages, hours, pensions or store closures under the new owners, so any claim about staff pay would be speculation.

The sources do point to the direction of travel. Rainmakers described the Westons as offering “patient capital” and said a stable owner with deep pockets could matter more to Nottingham than another change at the top. It also questioned whether the price paid is a genuine platform for growth, given pressure from cost inflation and online competition. That is analysis, not a commitment from the buyer.

On prices, the sources report no changes. Some shoppers quoted by the BBC already think sanitary products are “ridiculously expensive”, but that is a view on current pricing, not a forecast. The BBC’s analysts expect more investment in stores and services, which can be paid for in several ways. Until Boots says more, nobody is paying more or less because of the sale.

A worked example: what the Advantage card is worth

The one concrete number shoppers can use is the Advantage card. The BBC reports that it gives three points for every pound spent, with each point worth 1p. That is 3p back per £1, or a 3% return, and retail veteran Jackie Naghten told the BBC she does not expect the new owners to scrap it.

The table shows what that means at different levels of spending. The figures are our arithmetic from the BBC’s points rate, not a Boots statement.

A household spending £400 a year at Boots on skincare, first aid and medicine would earn 1,200 points, worth £12. One caveat from the BBC: customer Lewis Harrison said points can only cover a full transaction, unlike at Holland and Barrett. Retail expert Natalie Berg told the BBC the card is an asset the new owners “will want to double down on”. Any change to the rules would be a new announcement.

New Boots owner: pharmacy changes and what to do now

The new Boots owner has said it wants to expand the healthcare range, according to BeBeez, drawing on the Westons’ experience with Shoppers Drug Mart in Canada. The BBC reports that Boots already offers prescriptions and vaccinations in store, and said earlier this summer that it was expanding weight-loss drug services. Analysts quoted by the BBC link this to pharmacies being asked to take on more services to ease pressure on GP surgeries and hospitals.

For now, the practical steps are modest. Keep using your pharmacy as normal, because the deal has not completed and the sources report no changes to prescription services. If you hold an Advantage card, you can check your points balance, as no rule changes have been announced. If you work for Boots, watch for communication from the company, and from your union if you are a member, as the approvals process runs towards the first quarter of 2027.

If you are weighing up Boots against rivals, the BBC notes competition from Superdrug, and that M&S announced a Sephora partnership this week to replace a hundred of its own beauty departments next year. More choice usually helps shoppers, though the sources give no price comparison.

Your questions answered

Who is the new owner of Boots?

Wittington Investments, the holding company of Canada’s Weston family, has agreed to buy Boots, according to the BBC and BeBeez. Fairfax Financial Holdings will hold 50% of the equity as co-investor, but Wittington keeps operational control. The Westons also control Associated British Foods, the owner of Primark, the BBC said.

Is Boots being sold?

Yes. Sycamore Partners and Stefano Pessina’s family have agreed the sale, but BeBeez reports it needs the usual approvals and may complete in the first quarter of 2027. Sycamore took Walgreens Boots Alliance private in August 2025.

Who is the new CEO of Boots?

BeBeez reported that Boots appointed Alex Baldock, formerly chief executive of Currys and Very Group, in September 2026. It said he will keep the role after the sale. BeBeez also reported that Galen Weston will head Boots, and that Ornella Barra became chair of The Boots Group after standing down as chief executive on 26 January.